Blood
-
TIF News
-
News
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System
Hemanext Inc. announced today it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the…
Read More » -
News
Blood Under The Microscope Of The European Commission: An Article by TIF’s Executive Director
by Dr Androulla Eleftheriou The European Commission published in October 2019 the Evaluation Report of the European legal framework for quality standards and blood, tissues and cells. This framework is…
Read More » -
News
Revisiting The Use and Management of Blood in Europe in Times of Crisis and Beyond
About 25 million blood transfusions are administered to patients every year throughout the European Union. What may come to mind to most people when thinking about blood transfusion is acute…
Read More » -
Education
eThalED COURSE: Blood Transfusion in Thalassaemia by Dr. Farrukh Shah
TIF´s 4th Webinar for Medical Specialists and Healthcare Professionals, organised as part of our eThalED Course, was successfully held on Monday, 31 August 2020. Prof. Constantina Politis, Associate Professor of…
Read More » -
Scientific Literature
Challenging the Erythropoiesis Paradigm in β-Thalassemia
β-thalassemia is a genetic disorder due to defective β-globin synthesis that results in severe anemia. A hallmark of the disease is the massive expansion of the erythroid compartment associated with…
Read More » -
TIF News
”Blood Transfusion in Thalassaemia”: Save the Date for the Next TIF Webinar for Medical Specialists
TIF´s brand new Webinar, entitled ”Blood Transfusion in Thalassaemia” and organised as part of the eThalED Course, will be held on Monday, 31 August 2020, 15:00-16:00 EEST / 13:00-14:00 BST.…
Read More » -
TIF Publications
Blood & COVID-19 (2020)
A guide on blood adequacy and safety during the COVID-19 pandemic, based on official recommendations from internationally recognised bodies.
Read More » -
Scientific Literature
Challenges of Blood Transfusions in β-Thalassemia
Patients with β-thalassemia major (BTM) require regular blood transfusions, supported by appropriate iron chelation therapy (ICT), throughout their life. β-thalassemia is a global disease that is most highly prevalent in Southeast Asia, Africa,…
Read More » -
Scientific Literature
Amustaline-glutathione Pathogen-reduced Red Blood Cell Concentrates for Transfusion-dependent Thalassaemia
Transfusion-dependent thalassaemia (TDT) requires red blood cell concentrates (RBCC) to prevent complications of anaemia, but carries risk of infection. Pathogen reduction of RBCC offers potential to reduce infectious risk. We…
Read More »